文献速递血管炎其他结缔组织病

英国1997至2018年巩膜炎流行病学:1100万患者的人群分析及巩膜炎与感染性和免疫介导炎性疾病的相关性

Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease.
PubMed 文献 · Arthritis Rheumatol · 2021-06-06

该研究基于英国健康改善网络数据库,分析1997至2018年巩膜炎的患病率和发病率趋势,并探讨巩膜炎与感染性和免疫介导炎性疾病(I-IMID)的关联。研究发现巩膜炎发病率从4.23降至2.79/10万人年,2018年患病率为93.62/10万人年;巩膜炎患者中既往和后续I-IMID诊断风险显著增加,尤其与肉芽肿性多血管炎、白塞病和干燥综合征关联最强。

要点

  • 1997至2018年英国巩膜炎发病率从4.23降至2.79/10万人年。
  • 巩膜炎患者发生既往I-IMID风险为对照2倍,后续诊断风险也显著增加。
  • 与巩膜炎关联最强的I-IMID包括肉芽肿性多血管炎、白塞病和干燥综合征。

核心结论

  • 1997至2018年英国巩膜炎发病率下降,从4.23降至2.79/10万人年。
  • incident巩膜炎与19种I-IMID相关,为合理检查和跨专科协作提供数据。

研究设计与样本

  • 回顾性横断面和人群队列研究(1997-2018)纳入10,939,823名患者,其中2,946例 incident巩膜炎。
  • 病例对照和匹配队列研究(1995-2019)纳入3,005例 incident巩膜炎和12,020名对照,按年龄、性别、地区及Townsend剥夺指数匹配。
  • 使用多变量Poisson回归、多变量logistic回归和Cox比例风险多变量模型,调整年龄、性别、剥夺指数、种族/民族、吸烟状态、英国境内区域和体重指数。

主要发现

  • 巩膜炎发病率从1997年4.23(95%CI 2.16-6.31)降至2018年2.79(95%CI 2.19-3.39)/10万人年。
  • 2018年巩膜炎患病率为93.62(95%CI 90.17-97.07)/10万人年,对应61,650名英国患者。
  • 2,946例 incident巩膜炎中,1,831例(62.2%)为女性,平均年龄44.9±17.6岁(范围1-93),1,257例(88.8%)为白人。
  • incident巩膜炎风险升高与女性(调整IRR 1.53 [95%CI 1.43-1.66],P<0.001)、黑人种族/民族(调整IRR 1.52 [95%CI 1.14-2.01],P=0.004,对比白人)或南亚裔种族/民族(调整IRR 1.50 [95%CI 1.19-1.90],P<0.001,对比白人)以及年龄较大(51-60岁对比≤10岁,调整IRR峰值4.95 [95%CI 3.99-6.14],P<0.001)相关。
  • 与对照组相比,巩膜炎患者既往I-IMID诊断风险增加2倍(17种I-IMID,P<0.001),后续诊断风险也显著增加(13种I-IMID)。

关键数值与推荐

  • 与巩膜炎关联最强的I-IMID包括肉芽肿性多血管炎、白塞病和干燥综合征。

临床怎么用

  • 巩膜炎患者应评估既往和后续的I-IMID,尤其关注肉芽肿性多血管炎、白塞病和干燥综合征。
  • 女性、黑人/南亚裔及51-60岁人群发生巩膜炎风险较高,临床需提高警惕。
  • 研究结果为巩膜炎患者的合理检查和跨专科协作提供依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To estimate 22-year trends in the prevalence and incidence of scleritis, and the associations of scleritis with infectious and immune-mediated inflammatory diseases (I-IMIDs) in the UK. METHODS: The retrospective cross-sectional and population cohort study (1997-2018) included 10,939,823 patients (2,946 incident scleritis cases) in The Health Improvement Network, a nationally representative primary care records database. The case-control and matched cohort study (1995-2019) included 3,005 incident scleritis cases and 12,020 control patients matched by age, sex, region, and Townsend deprivation index. Data were analyzed using multivariable Poisson regression, multivariable logistic regression, and Cox proportional hazards multivariable models adjusted for age, sex, Townsend deprivation index, race/ethnicity, smoking status, nation within the UK, and body mass index. Incidence rate ratios (IRRs) and 95% confidence intervals (95% CIs) were calculated. RESULTS: Scleritis incidence rates per 100,000 person-years declined from 4.23 (95% CI 2.16-6.31) to 2.79 (95% CI 2.19-3.39) between 1997 and 2018. The prevalence of scleritis per 100,000 person-years was 93.62 (95% CI 90.17-97.07) in 2018 (61,650 UK patients). Among 2,946 patients with incident scleritis, 1,831 (62.2%) were female, the mean ± SD age was 44.9 ± 17.6 years (range 1-93), and 1,257 (88.8%) were White. Higher risk of incident scleritis was associated with female sex (adjusted IRR 1.53 [95% CI 1.43-1.66], P < 0.001), Black race/ethnicity (adjusted IRR 1.52 [95% CI 1.14-2.01], P = 0.004 compared to White race/ethnicity), or South Asian race/ethnicity (adjusted IRR 1.50 [95% CI 1.19-1.90], P < 0.001 compared to White race/ethnicity), and older age (peak adjusted IRR 4.95 [95% CI 3.99-6.14], P < 0.001 for patients ages 51-60 years versus those ages ≤10 years). Compared to controls, scleritis patients had a 2-fold increased risk of a prior I-IMID diagnosis (17 I-IMIDs, P < 0.001) and significantly increased risk of subsequent diagnosis (13 I-IMIDs). The I-IMIDs most strongly associated with scleritis included granulomatosis with polyangiitis, Behçet's disease, and Sjögren's syndrome. CONCLUSION: From 1997 through 2018, the UK incidence of scleritis declined from 4.23 to 2.79/100,000 person-years. Incident scleritis was associated with 19 I-IMIDs, providing data for rational investigation and cross-specialty engagement.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Braithwaite T, Adderley NJ, Subramanian A, et al. Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease. Arthritis Rheumatol. 2021. PMID: 33728815. doi:10.1002/art.41709

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。